144. レノックス・ガストー症候群 Lennox-Gastaut syndrome Clinical trials / Disease details


臨床試験数 : 111 薬物数 : 72 - (DrugBank : 14) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 61

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05626634
(ClinicalTrials.gov)
November 8, 202215/11/2022Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic EncephalopathyA Phase 2, Multicenter, Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy Who Completed Study LP352-201 and Are Candidates for Continuous Treatment for Up to 52 WeeksDevelopmental and Epileptic Encephalopathy;Dravet Syndrome;Lennox-Gastaut SyndromeDrug: LP352Longboard PharmaceuticalsNULLRecruiting12 Years65 YearsAll50Phase 2United States
2NCT05364021
(ClinicalTrials.gov)
March 3, 202222/3/2022Study to Investigate LP352 in Subjects With Developmental and Epileptic EncephalopathiesRandomized, Double-blind, Placebo-controlled, Parallel-group, Dose-escalation Study to Investigate the Safety, Tolerability, PK, PD, and Exploratory Efficacy of LP352 in Subjects With Developmental and Epileptic EncephalopathiesDevelopmental and Epileptic Encephalopathy;Dravet Syndrome;Lennox Gastaut SyndromeDrug: LP352;Drug: PlaceboLongboard PharmaceuticalsNULLRecruiting12 Years65 YearsAll50Phase 1/Phase 2United States